#BioManDACH2026 | Pharma & Biotech
The premier biopharma gathering driving bioprocess innovation and market growth across the DACH region
With the global biologics market expected to surpass $600 billion by 2030, driven by the rise of next-generation modalities and rapid advances in manufacturing technologies, Biologics Manufacturing DACH 2026 offers a premier platform for industry leaders to explore innovation, share expertise, and build strategic partnerships.
As the DACH region strengthens its role as a hub for cutting-edge biologics production, this conference brings together manufacturers, technology providers, and developers to tackle the industry’s most pressing challenges in a focused, highly networked setting.
The premier biopharma gathering driving bioprocess innovation and market growth across the DACH region
With the global biologics market expected to surpass $600 billion by 2030, driven by the rise of next-generation modalities and rapid advances in manufacturing technologies, Biologics Manufacturing DACH 2026 offers a premier platform for industry leaders to explore innovation, share expertise, and build strategic partnerships.
As the DACH region strengthens its role as a hub for cutting-edge biologics production, this conference brings together manufacturers, technology providers, and developers to tackle the industry’s most pressing challenges in a focused, highly networked setting.
Good to know
Highlights
- 1 day 10 hours
- In-person
Refund Policy
Location
Basel Marriott Hotel
25 Messeplatz
4058 Basel
How would you like to get there?
